Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Compugen Ltd.
  6. News
  7. Summary
    CGEN   IL0010852080

COMPUGEN LTD.

(CGEN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about COMPUGEN LTD.
11/29Compugen Wins Fortinet Achievement Award at NSE XPERTS Summit 2021
AQ
11/15Oppenheimer Adjusts Compugen PT to $17 From $19, Maintains Outperform Rating
MT
11/12COMPUGEN : Q3 Earnings Snapshot
AQ
11/12Compugen Narrows Net Loss in Q3, Revenue Gains on Milestone Payment
MT
11/12Press Release dated November 12, 2021 – “Compugen Presents Preliminary Resu..
PU
11/12Compugen Announces Collaboration Expansion with Bristol Myers Squibb alongside $20 Mill..
PU
11/12Compugen Presents Preliminary Results from Phase 1 Dose Escalation Monotherapy Study of..
PR
11/12Compugen Presents Initial Translational Data Supporting the Differentiation of PVRIG Co..
PR
11/12Compugen Presents Preliminary Results from Phase 1/2 Dose Escalation Study of COM701 wi..
PR
11/12Compugen Reports Third Quarter 2021 Results
PR
11/12Compugen Presents Initial Translational Data Supporting the Differentiation of PVRIG Co..
CI
11/12Compugen Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended Sept..
CI
11/11Compugen Receives $20 Million Investment From Bristol Myers; Shares Rise
MT
11/11Compugen Shares Rise 18% Premarket After Bristol Myers Investment
DJ
11/11Compugen Announces Collaboration Expansion with Bristol Myers Squibb alongside $20 Mill..
PR
More most relevant news
All news about COMPUGEN LTD.
11/29Compugen Wins Fortinet Achievement Award at NSE XPERTS Summit 2021
AQ
11/15Oppenheimer Adjusts Compugen PT to $17 From $19, Maintains Outperform Rating
MT
11/12COMPUGEN : Q3 Earnings Snapshot
AQ
11/12Compugen Narrows Net Loss in Q3, Revenue Gains on Milestone Payment
MT
11/12Press Release dated November 12, 2021 – “Compugen Presents Preliminary Resu..
PU
11/12Compugen Announces Collaboration Expansion with Bristol Myers Squibb alongside $20 Mill..
PU
11/12Compugen Presents Preliminary Results from Phase 1 Dose Escalation Monotherapy Study of..
PR
11/12Compugen Presents Initial Translational Data Supporting the Differentiation of PVRIG Co..
PR
11/12Compugen Presents Preliminary Results from Phase 1/2 Dose Escalation Study of COM701 wi..
PR
11/12Compugen Reports Third Quarter 2021 Results
PR
More news
News in other languages on COMPUGEN LTD.
11/12Compugen réduit sa perte nette au troisième trimestre et augmente ses revenus grâce à u..
11/11Les actions du secteur de la santé toujours en baisse juste avant la clôture de jeudi
11/11Les actions du secteur de la santé en baisse jeudi
11/11Compugen reçoit un investissement de 20 millions de dollars de Bristol Myers ; les acti..
07/28La perte de Compugen au deuxième trimestre se creuse en raison de la hausse des dépense..
07/15Compugen commence le dosage dans l'essai de phase 1 de la bithérapie pour les malignité..
06/30Compugen administre une dose à un premier patient dans le cadre d'une étude sur une thé..
05/13La perte nette de Compugen au premier trimestre se creuse ; les actions augmentent de 5..
05/10Compugen étend sa collaboration de recherche avec l'Université Johns Hopkins pour un no..
2020COMPUGEN : Announces First Development Milestone in License Agreement with AstraZeneca for..
More news
Analyst Recommendations on COMPUGEN LTD.
11/15Oppenheimer Adjusts Compugen PT to $17 From $19, Maintains Outperform Rating
MT
04/06COMPUGEN : SVB Leerink Adjusts Price Target on Compugen to $16 From $19, Maintains Outperf..
MT
More recommendations
Press releases
11/29Compugen Wins Fortinet Achievement Award at NSE XPERTS Summit 2021
AQ
11/12COMPUGEN : Q3 Earnings Snapshot
AQ
11/12Press Release dated November 12, 2021 – “Compugen Presents Preliminary Resu..
PU
11/12Compugen Announces Collaboration Expansion with Bristol Myers Squibb alongside $20 Mill..
PU
11/12Compugen Presents Preliminary Results from Phase 1 Dose Escalation Monotherapy Study of..
PR
More press releases
Upcoming event on COMPUGEN LTD.
12/07/21